Alejandra Mørk – Board Executive


Photo of Alejandro Mørk, Ph.D., of PSNClinical



Alejandra Mørk, born in 1961, has a master’s degree in pharmacy and a Ph.D. from the Danish Pharmaceutical University. Alejandra Mørk has more than 20 years experience with drug development in the areas of clinical development, regulatory affairs, project management as well as strategy and business development.

She worked for 18 years for Nycomed Pharma in various positions within R&D and held the position of senior vice president for International Product Development in Nycomed prior to the merger between Nycomed and Altana. In January 2008 Alejandra Mørk acquired KLIFO A/S together with two private investors.